Cargando…
In silico detection of inhibitor potential of Passiflora compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses
SARS-Cov-2(Covid-19) is a new strain of coronavirus and was firstly emerged in December 2019 in Wuhan, China. Now, there is no known specific treatment of Covid-19 available. COVID-19 main protease is a potential drug target and is firstly crystallised by Liu et al (2020). In the study, we investiga...
Autores principales: | Yalçın, Serap, Yalçınkaya, Seda, Ercan, Fahriye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096201/ https://www.ncbi.nlm.nih.gov/pubmed/33967343 http://dx.doi.org/10.1016/j.molstruc.2021.130556 |
Ejemplares similares
-
Determination of Potential Drug Candidate Molecules of the Hypericum perforatum for COVID-19 Treatment
por: Yalçın, Serap, et al.
Publicado: (2021) -
A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme()
por: Ercan, Selami, et al.
Publicado: (2021) -
Investigation of angucycline compounds as potential drug candidates against SARS Cov-2 main protease using docking and molecular dynamic approaches
por: Al-Bustany, Hazem Abbas, et al.
Publicado: (2021) -
In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
por: Abdelrady, Yousef A, et al.
Publicado: (2023) -
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
por: Rangsinth, Panthakarn, et al.
Publicado: (2021)